Targeted Oncology4h
FDA Updates Decision on ProSense Cryoablation for Early-Stage Breast Cancer
The FDA has extended its review of the ProSense cryoablation system for early-stage breast cancer, with a decision expected ...
IceCure Reports Updated Timeline and Progress with FDA Regarding Marketing Authorization for ProSense® Cryoablation in Early-Stage Breast Cancer
IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...
Koelis Announces Innovative Products at EAU 2025 enhancing MRI Fusion Biopsy Workflows and promoting Focal Therapy in Prostate Cancer
Fusion biopsy and patient follow-up with 3D mapping are the cornerstone of a successful Focal Therapy program. In line with ...
Pulsed Field Ablation Market to Hit USD 2,127.9 Million by 2032, Exhibiting a 38.90% CAGR – SNS Insider
According to Research by SNS Insider, The Pulsed Field Ablation Market Growth is Driven by Technological Advancements and Rising Prevalence of Atrial FibrillationPune, March 20, 2025 (GLOBE NEWSWIRE) ...